UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF ILLINOIS
September 19, 2011
IN RE: YASMIN AND YAZ (DROSPIRENONE) MARKETING, SALES PRACTICES AND PRODUCTS LIABILITY
The opinion of the court was delivered by: Herndon, Chief Judge:
This Document Relates to:
Amanda Wolcott v. Bayer HealthCare Pharmaceuticals, Inc., et al. No. 3:10-cv-12580-DRH-PMF
Anna Korbut v. Bayer HealthCare Pharmaceuticals, Inc., et al. No. 3:10-cv-11793-DRH-PMF
ORDER GRANTING PLAINTIFFS' MOTION TO DISMISS CERTAIN DEFENDANTS WITH PREJUDICE
The plaintiffs in the above captioned actions have filed motions to dismiss defendants Barr Laboratories ("Barr"), Inc. and Teva Pharmaceuticals USA, Inc. ("TUSA") (Wolcott Doc. 14; Korbut Doc. 12). Counsel for plaintiff states that counsel recently learned that Ocella*fn1 was not on the market prior to each of the above plaintiff's alleged injury. Therefore the injuries plaintiffs allegedly sustained cannot be attributed to the use of Ocella. Plaintiffs therefore request that defendants Barr and TUSA be dismissed with prejudice. No defendant has responded to either motion to dismiss.
Accordingly, the Court ORDERS as follows: Defendants, Barr Laboratories Inc. and Teva Pharmaceuticals USA, Inc., are hereby dismissed with prejudice.
Digitally signed by David R. Herndon Chief Judge United States District Court
Date: 2011.09.19 10:32:49 -05'00'